perimenostage

Last checked September 2026 against 29 sources · Editorial policy

Hot flash treatment: hormonal and non-hormonal options

The most effective hot flash treatment is hormone therapy: estrogen cuts hot flash frequency by about 75%. If you can't or don't want hormones, prescription options include fezolinetant (Veozah) and elinzanetant (Lynkuet), low-dose paroxetine and other SSRIs or SNRIs, gabapentin and oxybutynin, which reduce hot flashes by roughly 40% to 65%. CBT helps you cope. Over-the-counter supplements haven't been shown to work.

HRT is the most effective hot flash treatment. Non-hormonal options include fezolinetant, SSRIs, gabapentin and oxybutynin. How well each works, compared.

Hot flash treatment: expectation vs reality

What people often expect

“Hot flashes are something you just have to wait out, and cooling tricks and supplements are the best you can do”

What the evidence shows

Hot flashes last a median of 7.4 years, so waiting is a long wait, and effective medicines exist. The North American Menopause Society recommends hormone therapy first, and SSRIs, SNRIs, gabapentin, fezolinetant, oxybutynin, CBT and clinical hypnosis as non-hormonal options. It doesn't recommend supplements, herbal remedies, paced breathing or cooling techniques, because the evidence doesn't show they work.

How hot flash treatments work

Why hot flashes happen

Falling estrogen disturbs the brain's temperature control center. A signal called neurokinin B acts on KNDy neurons in this center, and when estrogen is low their activity changes, so small shifts in body temperature can trigger a hot flash. Up to 87% of women report hot flashes during or after the menopause transition. The newest non-hormonal drugs, fezolinetant and elinzanetant, work by blocking neurokinin receptors.

Learn more →

Hormone therapy for hot flashes

Estrogen, with a progestogen if you have a uterus, reduces hot flash frequency by about 75%, and oral and transdermal forms work equally well. It's the most effective option and also treats vaginal dryness and protects bone. For women under 60 or within 10 years of menopause without contraindications, the benefits outweigh the risks. Patches and gels avoid the clot risk of tablets.

Learn more →

Fezolinetant and elinzanetant: neurokinin blockers

Fezolinetant (Veozah, 45 mg once a day) blocks the neurokinin 3 receptor; elinzanetant (Lynkuet, 120 mg at bedtime) blocks both neurokinin 1 and 3. In trials, both reduced moderate to severe hot flashes more than placebo by week 4 and kept working at week 12. Both need liver blood tests: Veozah before starting and at months 1, 2, 3, 6 and 9, after rare cases of serious liver injury.

Learn more →

SSRIs and SNRIs for hot flashes

Low-dose paroxetine, 7.5 mg at bedtime (Brisdelle), is the only antidepressant FDA-approved for hot flashes; in two trials it reduced them from week 4, without weight gain or loss of libido. Escitalopram, venlafaxine and desvenlafaxine also work. In MsFLASH trials, venlafaxine cut hot flashes by 47.6% compared with 52.9% for low-dose estradiol and 28.6% for placebo. Paroxetine is a strong CYP2D6 inhibitor, so it can interact with other drugs.

Learn more →

Gabapentin for hot flashes

Gabapentin, an anti-seizure and nerve pain medicine, reduces hot flashes at 900 mg a day. In a trial of 420 women with breast cancer, 900 mg cut hot flash severity scores by 46% at 8 weeks, compared with 15% on placebo; 300 mg wasn't enough. In a smaller trial, 600 mg worked about as well as a low-dose estradiol patch. Drowsiness, dizziness and fatigue are the main side effects.

Learn more →

Oxybutynin for hot flashes

Oxybutynin, usually used for overactive bladder, also reduces hot flashes. In a 12-week trial, extended-release oxybutynin reduced moderate to severe hot flashes by 9.48 a day compared with 4.69 on placebo, 73% of women rated themselves much better, and sleep quality improved. Dry mouth affected 52.1% of women and led 6.8% to stop. The North American Menopause Society recommends it.

CBT and hypnosis for hot flashes

Cognitive behavioral therapy and clinical hypnosis are both recommended by The North American Menopause Society as non-drug hot flash treatments, with the strongest level of evidence. NICE recommends considering menopause-specific CBT alongside HRT or instead of it, and for people who can't take HRT. Weight loss is also on the recommended list for women who are overweight.

Learn more →

Over-the-counter hot flash treatments

No over-the-counter product has good evidence. In a meta-analysis, red clover didn't reduce hot flashes and soy results were mixed, and The North American Menopause Society doesn't recommend supplements, herbal remedies, soy or cannabinoids for hot flashes. Supplements aren't FDA-approved for any disease. Practical steps like layers and a fan make you more comfortable but haven't been shown to cut hot flashes.

Learn more →

Hot flash treatments by the numbers

From the studies on this page

  • reduction in hot flash frequency with estrogen therapy

    75%

  • reduction with non-hormonal medicines such as SSRIs, SNRIs and gabapentin

    40% to 65%

  • is the median duration of frequent hot flashes, so treatment often matters for years

    7.4 years

    Bar scaled to a 12-year reference span

  • reduction with placebo in an 8-week trial, which is why real effects are measured against it

    28.6%

Placebo effects in hot flash trials are large, so a treatment feeling like it works for a few weeks isn't proof. The figures above come from placebo-controlled trials.

Hot flash medications compared

  • Estrogen (HRT)

    Learn more →

    Good for
    Most effective, about 75% fewer hot flashes. Also treats vaginal dryness and prevents bone loss. Patches and gels avoid the clot risk of tablets.

    Watch
    Needs a progestogen if you have a uterus. Not for women with breast cancer, a past clot on tablets or liver disease.

  • Fezolinetant (Veozah)

    Learn more →

    Good for
    Non-hormonal, one 45 mg tablet a day, targets the brain signal behind hot flashes. Works from week 4.

    Watch
    Boxed warning for rare serious liver injury; liver blood tests before starting, monthly for 3 months, then at 6 and 9 months.

  • Elinzanetant (Lynkuet)

    Learn more →

    Good for
    Non-hormonal, two 60 mg capsules at bedtime, first approved in the US in 2025. Blocks two neurokinin receptors.

    Watch
    Can cause sleepiness, headache and fatigue; don't drive if affected. Liver tests before starting. Interacts with CYP3A4 drugs and grapefruit.

  • Low-dose paroxetine (Brisdelle) and other SSRIs/SNRIs

    Learn more →

    Good for
    Paroxetine 7.5 mg is FDA-approved for hot flashes and didn't cause weight gain or libido problems in trials. Venlafaxine, escitalopram and desvenlafaxine are alternatives that also help mood.

    Watch
    Paroxetine can reduce tamoxifen's effect, so it's usually avoided with tamoxifen. Nausea and sleep changes are common early on.

  • Gabapentin

    Learn more →

    Good for
    Cheap generic; 900 mg a day cut hot flash severity by 46% in a trial, and 600 mg matched a low-dose estradiol patch in another.

    Watch
    Drowsiness and dizziness are common. Doses below 900 mg didn't work in the main trial.

  • Oxybutynin

    Good for
    Cheap generic that halved hot flashes in a 12-week trial and improved sleep quality.

    Watch
    Dry mouth in about half of users, and 6.8% stopped because of it.

  • Clonidine

    Good for
    A blood pressure medicine that modestly reduced hot flashes in a meta-analysis and is used for them in the UK.

    Watch
    Smaller effect than other options, and The North American Menopause Society no longer recommends it for hot flashes.

How to choose a hot flash treatment

  1. Start with hormone therapy if you're under 60 or within 10 years of menopause and have no contraindications; it's the most effective.
  2. If you've had breast cancer or a clot, go straight to non-hormonal options, and avoid paroxetine with tamoxifen.
  3. If low mood or anxiety comes with the hot flashes, an SSRI or SNRI can help both.
  4. If night sweats wreck your sleep, ask about options taken at bedtime, such as elinzanetant, or CBT for insomnia.
  5. Give any treatment 4 to 12 weeks before judging it, the time frame used in trials.
  6. Skip supplements marketed for hot flashes; they aren't FDA-approved and haven't beaten placebo.

When hot flashes need a doctor

  • Hot flashes disrupting sleep, work or daily life

    See a doctor. Effective treatments exist, and you don't need to wait them out.

    More →
  • Night sweats with fever, weight loss or swollen glands

    See a doctor. These can have causes other than menopause.

    More →
  • Urgent: Yellow skin or eyes, dark urine or itching on Veozah or Lynkuet

    Stop the medicine and contact your doctor. These can be signs of liver injury.

  • Hot flashes starting while on tamoxifen or other breast cancer treatment

    Talk to your oncology team before starting any treatment, as some interact with cancer drugs.

Video: Hot flashes: why they happen, how long they last, and what actually helps

Read the transcript (728 words)▾

Four oh five. Checkout line. And then my face is on fire. That's a hot flash. Most women get them in the transition. Here's what's actually happening in your body, how long they last, and what the research says helps.

A hot flash is a sudden wave of heat through the face, neck and chest. Your skin flushes, you may sweat heavily, and your heart can race. It usually lasts a few minutes, and when the sweat cools, you can end up cold and shivery. Night sweats are the same thing, happening while you sleep.

It starts in the brain. Deep inside it, the hypothalamus works like a thermostat, and estrogen helps keep its comfortable range wide. As estrogen swings and falls, a group of nerve cells that use a messenger called neurokinin B becomes overactive. The comfortable range narrows. A tiny rise in body temperature, one you'd normally never notice, gets read as overheating. So your body dumps heat, fast. Blood vessels in the skin open, sweat starts, the heart speeds up. That's the flash. It's also why one of the newest non-hormonal medicines works by blocking neurokinin B instead of replacing estrogen.

Between fifty and seventy-five percent of women get hot flashes or night sweats during the transition, and a 2023 review puts it as high as eighty-seven percent at some point. In SWAN, frequent hot flashes lasted a median of seven point four years in total, and four and a half years after the final period. If they started early in the transition, the median was more than eleven point eight years. African American women had the longest course, a median of ten point one years. Women whose hot flashes only began after menopause had the shortest, three point four years.

At night, the same flash plays out in the dark. A wave of heat wakes you, you sweat through your nightclothes, then you're cold and wide awake. In SWAN, women with more frequent hot flashes had higher odds of every kind of sleep trouble, so night sweats are one of the main reasons sleep breaks down in perimenopause. A cool bedroom and breathable bedding help with comfort. For the sleep itself, cognitive behavioral therapy for insomnia has strong evidence: in a trial of women with hot flashes, eighty-four percent were in the no-insomnia range six months later, compared with forty-three percent who got education alone.

In the moment, a few simple things help: light layers you can take off, a fan, a cold drink, a cool shower, a cool bedroom at night. Spicy food, caffeine, hot drinks, alcohol and smoking are common triggers, so cutting back can help. Keeping to a healthy weight is also advised. None of these switch hot flashes off, but they can take the edge off.

Hormone therapy is the most effective option. Estrogen cuts hot flash frequency by about seventy-five percent, and tablets and patches work equally well. If you still have a uterus, estrogen is combined with a progestogen to protect its lining. For healthy women under sixty, or within ten years of their last period, the benefits generally outweigh the risks. Fezolinetant, a daily non-hormonal pill that blocks neurokinin B, is recommended at the highest level of evidence by the Menopause Society, and by UK guidelines when hormone therapy isn't suitable. Certain antidepressants and gabapentin reduce hot flashes by about forty to sixty-five percent, and oxybutynin, a bladder medicine, is also recommended. These are useful if you can't take hormones. Cognitive behavioral therapy and clinical hypnosis work less on the heat itself and more on how much hot flashes bother you, and on your sleep. And what the 2023 review didn't find support for: supplements and herbal remedies, soy, acupuncture, yoga and paced breathing.

Some sweats need a different explanation. Sweats with a fever, a cough, diarrhea or weight loss you can't explain. Feeling hot all the time rather than in waves, with shaky hands and a fast heartbeat at rest, which can point to an overactive thyroid. Sweating that started with a new medicine. Or hot flashes that appear for the first time many years after menopause. All of these deserve a doctor's look.

Hot flashes are common, they can last for years, and there are options that work at any stage. Find your stage in two minutes at perimenostage.com, and bring it to your doctor.

Every number in this video is sourced in the YouTube description.

Hot flash treatment: questions women ask

What is the most effective hot flash treatment?

Hormone therapy. Estrogen, alone or with a progestogen, reduces hot flash frequency by about 75%. Non-hormonal medicines such as SSRIs, SNRIs and gabapentin reduce them by about 40% to 65%. Estrogen also treats vaginal dryness and protects bone, which the non-hormonal medicines don't.

What is the best non-hormonal hot flash medication?

There's no single best one. Fezolinetant and elinzanetant target the cause most directly; low-dose paroxetine is FDA-approved and helps mood; gabapentin suits night sweats; oxybutynin is cheap and effective. The choice depends on your other conditions and medicines.

Related →

Is there an over-the-counter hot flash treatment that works?

Not one with good evidence. Red clover didn't work in a meta-analysis, soy results are mixed, and The North American Menopause Society doesn't recommend supplements or herbal remedies. Layers and a fan help comfort but don't reduce hot flashes.

Related →

Does oxybutynin work for hot flashes?

Yes. In a 12-week trial, extended-release oxybutynin reduced hot flashes by 9.48 a day compared with 4.69 on placebo, and 73% of women felt much better. Dry mouth is the main side effect, affecting about half of users.

Can Cymbalta or Pristiq help hot flashes?

Desvenlafaxine (Pristiq), an SNRI, reduces hot flashes and is among the options listed in a JAMA review. Duloxetine (Cymbalta) is also an SNRI, but it isn't one of the antidepressants listed with trial evidence in that review. Venlafaxine, a closely related SNRI, cut hot flashes by 47.6% in a trial.

How fast do hot flash medications work?

Most show an effect within 4 weeks, the first checkpoint in trials of paroxetine, fezolinetant and elinzanetant. Full benefit is usually judged at 12 weeks; for HRT, the NHS says it can take up to 3 months to work fully.

What can I take for hot flashes if I've had breast cancer?

Non-hormonal options: venlafaxine and gabapentin were tested in breast cancer survivors, and fezolinetant, elinzanetant and oxybutynin are further options. Paroxetine is usually avoided with tamoxifen because it can reduce tamoxifen's effect. Agree the choice with your oncologist.

Do I need a prescription for hot flash treatment?

Yes, for everything that works well: HRT, fezolinetant, elinzanetant, SSRIs, SNRIs, gabapentin and oxybutynin all need a prescription in the US. Over-the-counter supplements don't need one, but they're not FDA-approved and don't have good evidence. Telehealth menopause services can prescribe most of them.

Related →

Sources

  1. Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023;329(5):405-420.
  2. The North American Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
  3. Prescribing information: Lynkuet (elinzanetant capsules). Bayer HealthCare, 2026. DailyMed, US National Library of Medicine.
  4. Prescribing information: Veozah (fezolinetant tablets). Astellas Pharma, 2026. DailyMed, US National Library of Medicine.
  5. Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531-9.
  6. Conklin M, Santoro N. Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause. Ther Adv Reprod Health. 2023;17:26334941231177611.
  7. The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.
  8. Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810.
  9. Lederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023;401(10382):1091-1102.
  10. Pinkerton JV, Simon JA, Joffe H, et al. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials. JAMA. 2024;332(16):1343-54.
  11. US Food and Drug Administration. Drug safety communication: FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant). December 2024.
  12. Prescribing information: Brisdelle (paroxetine 7.5 mg capsules). Legacy Pharma, 2025. DailyMed, US National Library of Medicine.
  13. Simon JA, Portman DJ, Kaunitz AM, et al. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause. 2013;20(10):1027-35.
  14. Portman DJ, Kaunitz AM, Kazempour K, et al. Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause. Menopause. 2014;21(10):1082-90.
  15. Joffe H, Guthrie KA, LaCroix AZ, et al. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial. JAMA Intern Med. 2014;174(7):1058-66.
  16. Pandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005;366(9488):818-24.
  17. Aguirre W, Chedraui P, Mendoza J, et al. Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes. Gynecol Endocrinol. 2010;26(5):333-7.
  18. Simon JA, Gaines T, LaGuardia KD; Extended-Release Oxybutynin Therapy for VMS Study Group. Extended-release oxybutynin therapy for vasomotor symptoms in women: a randomized clinical trial. Menopause. 2016;23(11):1214-1221.
  19. NICE. Menopause: identification and management (NG23). Updated 2024.
  20. Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA. 2006;295(17):2057-71.
  21. US Food and Drug Administration. Dietary supplements.
  22. NHS. Treatment for menopause and perimenopause.
  23. NHS. Night sweats.
  24. Prescribing information: Divigel (estradiol gel 0.1%). Vertical Pharmaceuticals, 2026. DailyMed, US National Library of Medicine.
  25. NHS. Clonidine.
  26. NHS. About hormone replacement therapy (HRT).
  27. McCurry SM, Guthrie KA, Morin CM, et al. Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. JAMA Intern Med. 2016;176(7):913-20.
  28. NHS. Oestrogen tablets, patches, gel and spray: common questions.
  29. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356(9247):2059-63.

See our editorial policy.

Related guides

Doctor-ready summary

Your stage in 2 minutes.

You leave with a stage estimate and a one-page summary sized for a short appointment.

Begin 2-minute stage check

Private · No app download

Sample report

Stage estimateLate transition
Sleep driving burden · TSH worth ruling out